Chinese biopharma stocks surged in Hong Kong after reports that the US Treasury is drafting rules to allow American pharmaceutical companies to continue licensing most drugs from Chinese firms, excluding sensitive biotech related to pathogens. This proposed policy contrasts with tighter US restrictions on sectors like AI and semiconductors. Nearly half of US drug licensing deals in 2025 involved Chinese companies, highlighting the importance of this market. Despite geopolitical tensions, China's pharmaceutical sector is booming, with $110 billion in licensing deals in the first half of 2026, and the trend is expected to continue under China's five-year plan promoting globalization in biotech.
Chinese biopharma stocks are in focus as the US considers new drug licensing rules. For readers following health-sector stocks, here is Pluang's market snapshot as of Sep 21, 2026 11:31 WIB: out of 92 priced US health-sector stocks, 48 rose and 44 fell. Notable gainers include RXRX (Recursion Pharmaceuticals Inc) up 20.38% at USD 3.84, TWST (Twist Bioscience Corp) up 17.60% at USD 168.25, and BNGO (BioNano Genomics Inc) up 14.57% at USD 1.73, with typical hold times ranging from 22 to 48 days.
Sabre has already implemented agentic AI in travel booking and servicing through its MCP server, launched in 2025, enabling real-time AI-driven travel sales and support. With nearly 80 customers including Virgin Australia and Flight Centre, Sabre's t...
A global IBM study reveals 60% of employees worry AI is diminishing their skills, especially critical thinking. While CHROs emphasize the need for judgment in AI oversight, employees rank it lower, highlighting a skills perception gap. Nearly half of...
Bitcoin's price has risen to $80,402, marking a steady upward trend supported by buyers who have consistently raised the market floor since June. This growth has increased the percentage of Bitcoin supply in profit from 45% to 71%, signaling more hol...
Bitcoin recently closed above its 50-week moving average for the first time in 45 weeks, a key technical indicator suggesting the bear market may be over. The cryptocurrency rose nearly 6% in the week, trading around $81,450, and has gained 29% over ...
Pendle has introduced the NGI+ market, allowing DeFi users to trade fixed and variable yields on tokenized private infrastructure assets managed by Partners Group, which oversees $186 billion in assets. The NGI+ token offers a fixed yield of about 19...
